Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
setrobuvir
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Anadys
hepatitis C
M&A
Merck
Pegasys
Pharmasset
RG7128
Roche
setrobuvir
Victrelis
Hep C Drug Updates: Vertex and Anadys
Hep C Drug Updates: Vertex and Anadys
TheStreet.com
Anadys
hepatitis C
Incivek
setrobuvir
Vertex
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT